Megaoesophagus in Rassf1a-null mice

International Journal of Experimental Pathology

Volumn 90, Issue 2, 2009, Pages 101-108

  Van Der Weyden, Louise ^a   Happerfield, Lisa ^b   Arends, Mark J ^b   Adams, David J ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Achalasia; Histology; Megaoesophagus; Oesophagus; RASSF1

Indexed keywords

PROTEIN S 100; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; ESOPHAGUS ACHALASIA; FIBROSIS; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MEGAESOPHAGUS; MOUSE; MYENTERIC PLEXUS; NERVE CELL; NERVE FIBER; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; STRAIN DIFFERENCE; WILD TYPE;

EID: 62749203640     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00635.x     Document Type: Article

References (21)

1. Adams C.W., Brain R.H., Trounce J.R. (1976) Ganglion cells in achalasia of the cardia. Virchows Arch. A. Pathol. Anat. Histol. 372, 75 79.
2. Allen N.P., Donninger H., Vos M.D. et al. (2007) RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene 26, 6203 6211.
3. Cross F.S. (1952) Pathologic changes in megaesophagus (esophageal dystonia). Surgery 31, 647 653.
4. Diamant N., Szczepanski M., Mui H. (1973) Manometric characteristics of idiopathic megaesophagus in the dog: an unsuitable animal model for achalasia in man. Gastroenterology 65, 216 223.
5. Donninger H., Vos M.D., Clark G.J. (2007) The RASSF1A tumor suppressor. J. Cell Sci. 120, 3163 3172.
6. Farrokhi F. Vaezi M.F. (2007) Idiopathic (primary) achalasia. Orphanet J. Rare Dis. 2, 38.
7. Goldblum J.R., Rice T.W., Richter J.E. (1996) Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 111, 648 654.
8. Gruber H. (1978) Motor innervation of the striated oesophagus muscle. Part 1. Intramural distribution of the right and left vagus nerve in the rat oesophagus as revealed by the glycogen depletion technique. J. Neurol. Sci. 36, 41 53.
9. Harkness J.E. Ferguson F.G. (1979) Idiopathic megaesophagus in a rat (Rattus norvegicus). Lab. Anim. Sci. 29, 495 498.
10. Harris L.D., Ashworth W.D., Ingelfinger F.J. (1960) Esophageal aperistalsis and achalasia produced in dogs by prolonged cholinesterase inhibition. J. Clin. Invest. 39, 1744 1751.
11. Hull J., Rowlands K., Lockhart E. et al. (2004) Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum. Genet. 114, 272 279.
12. Luo G., Santoro I.M., McDaniel L.D. et al. (2000) Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat. Genet. 26, 424 429.
13. Maruyama R., Akino K., Toyota M. et al. (2008) Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer. Carcinogenesis 29, 1312 1318.
14. Randelia H.P. Lalitha V.S. (1988) Megaoesophagus in ICRC mice. Lab. Anim. 22, 23 26.
15. Randelia H.P., Panicker K.N., Lalitha V.S. (1990) Megaoesophagus in the mouse: histochemical and ultrastructural studies. Lab. Anim. 24, 78 86.
16. Raymond L., Lach B., Shamji F.M. (1999) Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 35, 445 453.
17. Tommasi S., Dammann R., Zhang Z. et al. (2005) Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 65, 92 98.
18. Weisbrodt N.W. (1976) Neuromuscular organization of esophageal and pharyngeal motility. Arch. Intern. Med. 136, 524 531.
19. van der Weyden L. Adams D.J. (2007) The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim. Biophys. Acta 1776, 58 85.
20. van der Weyden L., Tachibana K.K., Gonzalez M.A. et al. (2005) The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol. Cell. Biol. 25, 8356 8367.
21. van der Weyden L., Arends M.J., Dovey O.M. et al. (2008) Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis. Oncogene 32, 4503 4508.